HealthEquity, Inc. (NASDAQ:HQY) major shareholder Berkley Capital, Llc sold 23,479 shares of the stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $51.08, for a total value of $1,199,307.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Berkley Capital, Llc also recently made the following trade(s):

  • On Monday, November 6th, Berkley Capital, Llc sold 373,500 shares of HealthEquity stock. The stock was sold at an average price of $53.21, for a total value of $19,873,935.00.
  • On Thursday, November 2nd, Berkley Capital, Llc sold 13,600 shares of HealthEquity stock. The stock was sold at an average price of $51.02, for a total value of $693,872.00.
  • On Thursday, October 12th, Berkley Capital, Llc sold 11,395 shares of HealthEquity stock. The stock was sold at an average price of $51.91, for a total value of $591,514.45.
  • On Monday, October 9th, Berkley Capital, Llc sold 1,100 shares of HealthEquity stock. The stock was sold at an average price of $51.95, for a total value of $57,145.00.
  • On Friday, October 6th, Berkley Capital, Llc sold 29,032 shares of HealthEquity stock. The stock was sold at an average price of $51.97, for a total value of $1,508,793.04.
  • On Thursday, October 5th, Berkley Capital, Llc sold 286,512 shares of HealthEquity stock. The stock was sold at an average price of $51.96, for a total value of $14,887,163.52.

Shares of HealthEquity, Inc. (HQY) traded down $0.57 during trading hours on Friday, hitting $50.17. The stock had a trading volume of 238,743 shares, compared to its average volume of 532,719. HealthEquity, Inc. has a one year low of $37.62 and a one year high of $55.31. The firm has a market cap of $3,070.00, a price-to-earnings ratio of 79.00, a PEG ratio of 2.18 and a beta of 1.77.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 5th. The company reported $0.27 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.14 by $0.13. The business had revenue of $56.90 million during the quarter, compared to the consensus estimate of $55.66 million. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. HealthEquity’s revenue was up 28.7% on a year-over-year basis. During the same quarter last year, the company earned $0.16 EPS. sell-side analysts anticipate that HealthEquity, Inc. will post 0.7 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “HealthEquity, Inc. (HQY) Major Shareholder Sells $1,199,307.32 in Stock” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another website, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this story can be read at https://www.thecerbatgem.com/2017/11/17/healthequity-inc-hqy-major-shareholder-sells-1199307-32-in-stock.html.

Institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in shares of HealthEquity by 3.0% during the 2nd quarter. Vanguard Group Inc. now owns 4,237,298 shares of the company’s stock worth $211,145,000 after buying an additional 122,061 shares during the period. First Trust Advisors LP raised its position in HealthEquity by 17.0% in the 2nd quarter. First Trust Advisors LP now owns 94,283 shares of the company’s stock valued at $4,698,000 after purchasing an additional 13,676 shares during the last quarter. Dimensional Fund Advisors LP raised its position in HealthEquity by 25.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 473,433 shares of the company’s stock valued at $23,591,000 after purchasing an additional 95,514 shares during the last quarter. Fred Alger Management Inc. raised its position in HealthEquity by 30.4% in the 2nd quarter. Fred Alger Management Inc. now owns 265,369 shares of the company’s stock valued at $13,223,000 after purchasing an additional 61,880 shares during the last quarter. Finally, Russell Investments Group Ltd. bought a new position in HealthEquity in the 2nd quarter valued at $1,362,000. Institutional investors and hedge funds own 91.75% of the company’s stock.

HQY has been the topic of a number of analyst reports. TheStreet raised HealthEquity from a “c” rating to a “b” rating in a report on Monday, July 31st. Cantor Fitzgerald reissued a “buy” rating and set a $56.00 price objective on shares of HealthEquity in a report on Monday, September 25th. Zacks Investment Research raised HealthEquity from a “hold” rating to a “buy” rating and set a $58.00 price objective on the stock in a report on Wednesday, October 11th. Oppenheimer Holdings, Inc. reissued a “buy” rating and set a $61.00 price objective on shares of HealthEquity in a report on Wednesday, September 6th. Finally, BidaskClub lowered HealthEquity from a “buy” rating to a “hold” rating in a report on Monday, July 24th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. HealthEquity presently has an average rating of “Buy” and an average target price of $57.50.

HealthEquity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Stock Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related stocks with our FREE daily email newsletter.